Dear colleagues!
On August 28, 2026, the full texts of the new clinical guidelines were published on the official website of the European Society of Cardiology (ESC), dedicated to the issues of cardiovascular diseases and chronic kidney disease.
The provisions of these clinical recommendations were presented to the participants of a number of specially organized scientific sessions, and also served as a reason for active discussions.
Risk Model Validates Finerenone Effect in Heart Failure
The Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction (PREDICT-HFpEF) tool effectively stratified cardiovascular risk, with risk being higher in the highest than in the lowest score quintile. Finerenone was consistently effective across risk levels in patients with heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), with a large absolute benefit observed in high-risk patients.
Muslim fasting from a medical point of view
Dear colleagues!
We offer you an article by Professor Mekhman N. Mamedov about medical aspects of muslim fasting and practical advice for applicants.
ACC Clinical Bulletin Focuses on Cardiac Implications of Coronavirus (COVID-19)
The bulletin provides background on the epidemic, which was first reported in late December 2019, and looks at early cardiac implications from case reports.
Eating An Egg A Day Is A-OK, Despite Heart Disease History, New Study Suggests
Interest in high-protein and high-fat diets like the keto diet keeps growing, but concerns about the health effects of many foods on those diets remain high. For at least one of those foods—the simple protein-packed egg—a new, large-scale study suggests that devouring one a day is fine for most people, even those with a history of heart disease.
Marijuana may cause the same cardiovascular damage as cigarettes
More than two million Americans with heart disease are using or have used marijuana - and it could put them at risk of dangerously heavy bleeding and other complications, a new study warns.
Don't Stop the Statin! Christopher P. Cannon
Lipid lowering with statins is one of the most beneficial therapies in cardiovascular medicine, with evidence from hundreds of randomized clinical trials, including >25 large cardiovascular outcomes trials in the Cholesterol Treatment Trialists (CTT) collaboration.
Expert point of view
Strategies to Overcome Residual Risk During Statins Era
PreHT 2020|Vilnius | Lithuania | 2-5 April 2020
7th International Conference on Prehypertension, Hypertension, Metabolic Disorders and Cardiovascular Disease (PreHT 2020)
RU
EN
